tiprankstipranks
Krystal Biotech (KRYS)
NASDAQ:KRYS

Krystal Biotech (KRYS) Ownership - Who Owns Krystal Biotech?

404 Followers

Krystal Biotech (KRYS) Ownership Overview

24.14%27.09%14.92%33.85%
24.14% Insiders
14.92% Other Institutional Investors
33.85% Public Companies and
Individual Investors
The ownership structure of Krystal Biotech (KRYS) stock is a mix of institutional, retail and individual investors. Approximately 42.00% of the company’s stock is owned by Institutional Investors, 24.14% is owned by Insiders and 33.85% is owned by Public Companies and Individual Investors.
The ownership structure of Krystal Biotech (KRYS) stock is a mix of institutional, retail and individual investors. Approximately 42.00% of the company’s stock is owned by Institutional Investors, 24.14% is owned by Insiders and 33.85% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 09, 2023Sold$6417774
Jun 02, 2023
Suma Krishnan
President, R&d,director, >10% Owner
Sold$5809610
Jun 02, 2023
Krish Krishnan
President & Ceo,director, >10% Owner
Sold$5809610

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Sold$933799
Dec 31, 2023Bought$13673272
Dec 31, 2023Sold$24363647
Dec 31, 2023Bought$59794314

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,329,136Institution8.23%381,908,430
2,168,819Institution7.67%355,621,251
2,070,322Institution7.32%339,470,698
971,830Institution3.43%159,350,965
481,979Institution1.70%79,030,097
455,422Institution1.61%74,675,545
337,907Institution1.19%55,406,611
242,063Institution0.86%39,691,070
238,171Institution0.84%39,052,899
233,261Institution0.82%38,247,806

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,168,819Institution7.67%355,621,251
2,070,322Institution7.32%339,470,698
337,907Institution1.19%55,406,611
242,063Institution0.86%39,691,070
238,171Institution0.84%39,052,899
233,261Institution0.82%38,247,806
231,162Institution0.82%37,903,633
207,424Institution0.73%34,011,313
167,043Institution0.59%27,390,041
136,485Institution0.48%22,379,445

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
767,054Institution2.71%136,481,918
611,548Institution2.16%108,812,736
512,476Institution1.81%84,030,690
412,203Institution1.46%73,343,280
419,136Institution1.48%71,102,231
366,117Institution1.29%65,143,198
186,355Institution0.66%30,556,629
176,075Institution0.62%28,871,018
115,469Institution0.41%19,588,161
80,682Institution0.29%14,355,748

FAQ

Who Owns Krystal Biotech (KRYS)?
According to the latest TipRanks data, approximately 14.92% of the company's stock is held by institutional investors, 24.14% is held by insiders, and 33.85% is held by retail investors.
    What percentage of Krystal Biotech (KRYS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 14.92% of Krystal Biotech (KRYS) stock is held by institutional investors.
      What percentage of Krystal Biotech (KRYS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 33.85% of Krystal Biotech (KRYS) stock is held by retail investors.
        Who owns the most shares of Krystal Biotech (KRYS)?
        Vanguard owns the most shares of Krystal Biotech (KRYS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis